Abstract Anglotensm-(l-7) 1s a novel pepttde of the renlnanglotensm system that counteracts the pressor and prohferatlve responses to anglotensm II We now report that cultured bovme aortlc endothellal cells contam a saturable, high-affinity ['?]anglotensm-(l-7) bmdmg site with an affmlty of 19 3% 10 7 nmol/L and a density of 1351+710 fmol/mg protem Anglotensm-(1-7) competed at a second lower-affimty site, with an IC& of 2 9 PmollL The high-affinity anglotensm II receptor antagonist sarcosmel-lsoleucme*-anglotensm II blocked ["?]anglotensm-(l-7) bmdmg to bovine aortlc endothehal cells at both a high-(ICsO= 1 3 nmol/L) and a low-affimty (I&=6 2 /Imol/L) bmdmg site In contrast, D-alanme'-anglotensm-( l-7) completely blocked ['251]anglotensm-(1-7) bmdmg, with an IC50 of 19 8 nmol/L, suggesting that D-alanme'-anglotensm-( l-7) may selectively block responses to anglotensln-(l-7) In endothehal cells
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Neither the AT, antagomst losartan nor the AT2 antagonist PD 123319 exhibited slgmficant competltlon for ['251] anglotensm-(l-7) bmdmg to endothehal cells isolated from bovine aorta, m agreement with the absence of detectable mRNAs encoding typlcal anglotensm receptor subtypes I or 2 (AT, or AT2) Anglotensm II also competed for [ '251 ]anglotensm-( l-7) bmdmg to bovine aortlc endothehal cell?, however, the relative affinity was 13-fold lower than anglotensm-(l-7), suggestmg a preference for anglotennn-( 1-7) over anglotensm II These results demonstrate that bovi ne aortlc endothehal cells contam a unique non-AT,, non-AT2 anglotensm receptor that preferentially binds anglotensm-( l-7) (Hypertension. 1997; 29[part 2]:388-393.) Key Words l angiotensin-(l-7) l angiotemin II l angiotensm receptor subtypes l endothelmm l vascular A ng-( l-7), the N-terminal heptapeptide fragment of Ang II, was identified m the plasma and &sues of animals and humans, at concentrations slmliar to Ang 11 I-6 In addition, clrculatmg levels of Ang-(l-7) increased after treatment of rats, dogs, or humans with ACE inhlbltorsl-6 or hypertensive rats with the AT, antagonist losartan 2 We showed that Ang-(l-7) 1s generated from either Ang 1 or Ang 11 by tissue endopeptldases, including neutral endopeptldase 24 11 (nepnlysm), prolyl endopeptldase, or metallopeptldase 24.15 (thlmet oligopeptldase) 7-11 Thus, Ang-( l-7) is an endogenous component of the remn-anglotensm system, and peptlde levels are significantly elevated after treatment with ACE mhlbltors or ATI receptor antagonists Ang-( l-7) was ongmally consldered an inactive product of Ang 11 metabolism, on the basis of its mablhty to mimic the dipsogemc, vasoconstrlctor, or aldosterone-secretmg actions of Ang II.12 It 1s now known that Ang-(l-7) is a biologically active peptlde hormone having dlstmct and often opposite effects from those of Ang II Ang-( l-7) stimulates the actlvlty of neuropeptlderglc neurons that regulate vasopressm production and transmltter releasel3J4 and releases prostaglandms from astrocytes, smooth muscle cells and vascular endothehal cells 15-19 In contrast to the vasoconstnctlve effects of Ang 11, Ang-(l-7) acts as a vasodllator agent when mJetted mto a vem,2o causes vasorelaxation of coronary artery rmgs,21J2 plal arterioles,23 and mesenterlc arterles,24 and reduces blood pressure m SHR20 and renovascular hypertensive dogs 25 In addltlon, we recently From The Hypertension Center, Bowman Gray School of Medlcme of Wake Forest Umverslty, Winston-Salem, NC
Correspondence to E Ann Tallant, The Hypertension Center, Bowman Gray School of Medlcme, Medical Center Blvd, WmstonSalem, NC 27157-1032 0 1997 American Heart Associdtion, Inc showed that VSMC growth IS Inhibited by Ang-( l-7), m contrast to the growth-stlmulatory effects of Ang II 26 Thus, Ang-( 1-7) 1s a blologlcally active peptlde that opposes the pressor and prohferatlve effects of Ang II. Although the characterlstlcs of an anglotensm peptlde receptor that bmds Ang-(l-7) were not previously described, we showed that the depressor and antlprohferatlve responses to Ang-(l-7) are inhibited by the nonselective sarcosme analogs of Ang II, but not by AT,-or AT?-selective antagonists In pithed rats, the vasodepressor actlons of Ang-(l-7) were unaffected by the AT, antagonist losartan or the AT2 antagonist PD123319 but were mhiblted by Sar'-Thr'-Ang Il.27 Sari-Thr'-Ang 11 or Sar'-Ileg-Ang 11 blocked VSMC growth mhlbltlon by Ang-(l-7), but AT,-or AT?-selective receptor antagonists were ineffective 26 Furthermore, the vasodrlatlon of canine or porcine coronary arteries by Ang-(l-7) was blocked by removal of the endothelmm or by Sar'-Thr'-Ang 11 *1,22 However, neither an AT, nor an AT2 antagonist blocked the vasodllatlon by Ang-( l-7) m porcme or canine rmgs These results strongly suggest that Ang-(l-7) activates a unique non-AT,, non-AT, anglotensm receptor The current study was undertaken to characterIze the endothehal receptor activated by Ang-( l-7) Methods Cell-Culture Procedures BAEC were isolated from bovine thoraclc aorta obtained from a local slaughterhouse and transported to the laboratory m icecold PBS (50 mmol/L NaHP04, 0 15 mol/L NaCI, pH 7 2) supplemented with antlblotlcs (100 pg/mL pemcdlm, 100 U/mL streptomycm, and 50 bg/mL Fungizone) 28 Adipose and connective tissues were removed from the aorta to free the mtercostal vessels, which were tied with 3-O silk thread For release of the endothehal cells, warm dlspase (50 U/mL, Collaborative Research) m DMEMiF12 (50 50) containing antlblotlcs was mcubated m the lumen of the aorta for 20 minutes The aorta was washed with the same media supplemented with 10% FBS and heparm (100 bg/mL) The detached cells were isolated from the pooled mcubation media and wash by centrifugatlon at 1OOOg The cell pellet was resuspended m DMEM/F12 contammg serum, heparm, and antibiotics and plated at a concentration of approximately 1X104 cells/cm' The cultures were incubated m a humtdlfied 37°C incubator gassed with 5% COz and 95% room au The culture media was replaced on day 1 and every 2 to 3 days afterward Subcultures were developed using trypsm-EDTA (0 01% trypsm, 0 02% EDTA) at a ratio of 1 5 to 10 Cells were used between passage 1 and 4 BAEC were characterized by then morphology as polygonal cells forming a tight-fitting monolayer with a "cobblestone" appearance as well as by posittve rmmunofluorescent stammg with an antibody against factor VIII (von Willebrand factor) Contammation by fibroblasts or VSMC was determined by positive immunoreacttvlty using antibodies against fibronectm and VSMCspecific o-actm, respectively For indirect lmmunofluorescent microscopy, cells growing on coverslips were fixed with 100% methanol for 5 minutes at -20°C Fatty acid-free BSA was added to prevent nonspecific binding Antibodies agamst human factor VIII (Sigma Chemical Co, 1 loo), smooth muscle-specific rw-actm (Sigma, 1 loo), or fibronectm (Sigma, 1 100) were mcubated with the cells for 2 hours at room temperature The covershps were incubated for an additional 30 minutes m FITC-conjugated second antibody (either rabbit or mouse, Organon Tekmka Corporation; 1 200) The lmmunofluorescent products were visualized by using a fluorescent mtcroscope Preparation of BAEC Membranes BAEC were washed with cold PBS and physically detached by using a rubber pohceman Cells were collected by centnfugation at 15OOg for 5 minutes The cell pellet was immediately used for the preparation of membranes or frozen at -80°C for subsequent membrane preparation There was no stgmficant dtfference m bmdmg to membranes isolated from freshly isolated cells compared with frozen cells
The cell pellet was homogenized m cold PBS contammg 5 mmol/L EDTA, using 10 strokes of a glass/Teflon tissue homogenizer Membranes were isolated by centnfugatton at 30 OOOg for 20 mmutes at 4°C and resuspended m HEPES-buffered salme (10 mmol/L HEPES, 0 1 mol/L NaCl, 5 mmol/L MgCl*, pH 7 4) contammg 0 2% BSA and a cocktail of pepttdase mhtbttors (1 mmol/L EGTA, 1 mmol/L PMSF, 0 1 mg/mL soybean trypsm mhrbltor, 2 pmol/L. leupeptm, the prolyl endopepttdase mhrbttor Z-proprolmal [lo pmol/L], the nepnlysm mhlbltor SCH 39370 [ 10 PmollL], the ammopeptrdase mhibitors bestatm and amastatm [both at a concentration of 10 pmol/L]) Protein was measured using the procedure of Lowry.29 Membranes were immediately used for bmdmg
Iodination and HPLC Purification of Ang-( l-7)
Ang-(l-7) was todmated using chloramme T and separated from duodmated peptide by HPLC, using procedures established m our laboratory * 1130 Radiolabeled Ang-(l-7) was extracted with methanol/TFA and chromatographed on a Waters Nova-Pak Cl8 column (2 1 x 150 mm) using an HFBA solvent system, con- Binding assays were conducted usmg Isolated membranes m HEPES-buffered salme (10 mmol/L HEPES, 0 10 mol/L NaCl, 5 mmol/L MgC&, pH 7 4) contammg 0 2% BSA and the cocktail of peptldase mhlbrtors, as described above Nonspecific bmdmg was measured m the presence of 10 PmollL unlabeled Ang-(1-7). Saturation isotherms were constructed by mcubatton with mcreasmg concentrations of the radiohgand (from 0 1 to 22 nmol/L) to determine bmdmg affinities (&) and maximal bmdmg capacity (B,,,) For pharmacological characterizatton, competttlon curves were constructed by mcubation with 0.75 nmol/L [ '251]Ang-(l-7) and increasing concentrations (from lo-"' to 10m5 mol/L) of competing unlabeled Ang-(l-7), Ang II, or competmg hgand [the AT, antagonist losartan, the AT2 antagonist PD 123319, the sarcosme analog of Ang II Sar'-Ile*-Ang II, or p-Ala'-Ang-( l-7)] After a 45-minute mcubatlon at room temperature, assays were terminated by vacuum filtration over glass fiber filters (GFIS) presoaked m 0 5% BSA. The filters were washed with 4X2 mL PBS Radtoactlve content on dried filters was quantified m a gamma counter Bmdmg isotherms were analyzed by Scatchard plots, using the EBDA/Ligand computer program (Elsevler-BIOSOFT). The results are expressed as meantSEM
Competttlon bmdmg data were fit to models with both one and two binding sites by nonlinear regression analysts using the computer program PRISM Goodness of fit was quantified by the sum of squares The simpler equation was deemed the best fit unless the probablbty value was less than 05. To determme whether the amount of bmdmg at each concentratton of competmg peptide or antagonist was stgmficantly different from total binding, values were compared by one-way ANOVA, and significant differences were determined by Dunnett's post test, using the stattsttcs program INSTAT (GraphPad Software) RT-PCR of AT1 and AT, Receptor mRNA Total RNA was extracted from BAEC and bovme adrenal gland using TRIZOL accordmg to the manufacturer's directtons (GIBCO-BRL) RNA was incubated with RQl RNase-free DNase to degrade contammatmg DNA, and purified by phenolchloroform extraction and ethanol prectpitatlon AMV reverse transcriptase and random primers were used to prepare cDNA from 1 pg of the treated RNA. One tenth of this reaction product was used for PCR To detect AT, mRNA, primers specific for the gene encoding the bovine AT, receptor were prepared (sense S'CACCTATGTAAGATCGCTTC3', anttsense S'AGCCTTC TTGAGGGTCTTCCA3') 31 Since the DNA sequence of the bovine AT2 receptor 1s not available, primers were designed on the basis of regions of complete sequence homology between the human and rat AT2 genes (sense 5'TCTTATAGATATGACTG GCTC3', annsense S'AAGTGCCAGGTCAATGACTGC3') ?2s1 For ampbficatlon of AT, and AT2 receptor sequences, an mittal denaturatlon step at 92°C for 7 minutes was followed by 35 cycles of 92°C for 1 minute (denaturation), 58°C for 1 minute (annealing), and 72°C for 1 5 minutes (extension). A final mcubatlon at 72°C for 5 minutes ensured complete extension of the PCR products Reaction products were separated by polyacrylamtde gel electrophoresis, and the dried gels were analyzed by autoradiography Materials '251-Sodmm iodide (carrier free, 100 mCl/mL) was obtained from the Amersham Corporation DMEM/FlZ and FBS were obtamed from MediaTech Pemclllm, streptomycm, and trypsml EDTA were purchased from GIBCO Ang II, Ang-(l-7), and Sar'-Ile*-Ang II were obtamed from Bachem Inc o-Ala7-Ang-(l-7) was synthesized by the Protein Analysis Core of the Comprehensive Cancer Center at Wake Forest University Losartan 
Results
Isolated BAEC exhibited typical endothehal cell morphology, forming a confluent monolayer of polygonal cells "cobblestoned" m appearance Cultured BAEC were greater than 95% pure, as determined by positive tmmunoreactivity with antibodies against von Wtllebrand factor (Factor VIII) A small number of contaminating cells (<5%) stained posittvely with an anttbody against smooth muscle-specific a-actm There were no positively stamed cells usmg an antibody against fibronectm, mdtcatmg the absence of any contaminating fibroblasts Optimal binding of ['251]Ang-(1-7) was observed m HEPES-buffered salme solution contammg 0.2% BSA to reduce nonspectfic bmdmg and a cocktail of protease mhtbttors to prevent breakdown of the radiolabel to smaller fragments. In prehmmary studies, we measured the bmdmg of [ "'I]Ang-( l-7) to membranes isolated from BAEC as a function of mcubatton time and protein concentratton. Maximal bmdmg was obtained after a 45mmute mcubanon with 20 pg of endothehal cell membranes, conditions subsequently used for all studies BAEC membranes were incubated with mcreasmg concentrations of ['251]Ang-(1-7), from 0 1 to 22 nmol/L, to determine the optimal concentrattons of the peptide for bmdmg Nonspecific bmdmg was measured m the presence of 10 pmol/L unlabeled Ang-( l-7) and averaged from 10% to 20% of the total amount of bmdmg A typical saturation isotherm 1s shown m To determme whether BAEC also contain a lower-affinity bmdmg sue, competmon curves were generated using 0.75 nmol/L [ '*'IlAng-( l-7) and mcreasmg concentrations of Ang-(l-7) from lo-" to 10m5 mol/L Ang-( l-7) caused a dose-dependent mhtbttton of binding, as shown m Rg 2 Ang-( l-7) competed for 54% of the total amount of bmdmg with an ICso of 10 2 nmol/L, corresponding to the high-affinity site identified by Scatchard analysis Competmon for the remammg 46% of the bmdmg sites by Ang-(l-7) was of lower affinity, with an I& of 2.9 pmol/L.
The competttion for ['251]Ang-(1-7) bmdmg to BAEC was measured by mcreasmg concentrattons of the AT, antagonist losartan, the AT, antagonist PD 123319, and the nonselective sarcosme analog antagonist Sar'-IleX-Ang II, to examme the receptor subtype bmdmg Ang-(l-7) The competmon by D-Ala'-Ang-(l-7), which blocked the anttdmrettc effect of Ang-(l-7) m water-loaded rats,34 was also assessed The specific binding of '251-Ang-(1-7) was blocked by Sar'-Ile*-Ang II, as shown m OJ -10 -9 43 -7 -6 -5 Total RNA was isolated from BAEC and analyzed by PCR using primers based on the cloned AT, and AT2 receptors to assess the presence of the mRNA encoding a typical AT, or AT2 receptor in BAEC. As a control, total RNA was isolated from bovine adrenal tissue which contains both AT, and AT2 receptors.35,36 PCR analysis of DNA isolated from BAEC using the primers for either the ATI or AT2 receptors yielded products of the expected sizes (data not shown), demonstrating that the primers amplified DNA sequences specific for the AT, or AT2 receptors. As shown in Fig 4, both AT1 and AT2 mRNAs were detected in bovine adrenal tissue by RT-PCR. However, neither the AT, nor the AT2 mRNA was detected in BAEC.
The competition for [ i251]Ang-( l-7) binding was measured by increasing concentrations of Ang II, to determine the selectivity of this binding site for angiotensin peptides. The best-fit curve of the competition data shows that Ang II competed at a single site with an IC5,, of 131 nmol/L (derived from the competition for ['2TI]Ang-(1-7) by lo-" to 10m5 mol/L Ang II in cell membranes isolated from three different animals; data not shown). This indicates that Ang II competes for [ '251]Ang-( 1-7) binding with an affinity 13-fold lower than Ang-(l-7), suggesting that the endothelial Ang-( 1-7) binding site prefers Ang-( 1-7) over Ang II.
Discussion
This study shows, for the first time, that Ang-(l-7) binds to a novel angiotensin peptide receptor that does not recognize selective AT, or AT2 receptor antagonists. In addition, the mRNAs for the typical AT, or AT1 receptors were not expressed in BAEC. The Ang-( l-7) binding was saturable, of high affinity, and was not inhibited by the AT, antagonist losartan or the AT2 antagonist PD 123319. In contrast, [ '*?]Ang-( 1-7) binding was prevented by Sar'-Be'-Ang II, in agreement with previous studies showing that sarcosine derivatives of Ang II blocked responses to Ang-( 1-7) in both the endothelium*r,22 and cultured vascular cells. 19 26 [ 1251]Ang-( 1-7) binding to BAEC was completely inhibited by o-Ala7-Ang-( l-7), with an IC50 of 19.8 nmol/L. Santos et alY4 showed that D-Ala7-Ang-(1-7) selectively blocked the antidiuretic effects of Ang-(l-7) in water-loaded rats as well as the changes in blood pressure produced by Ang-(l-7) injection into the medulla oblongata. Furthermore, D-Ala7-Ang-( 1-7) did not compete for binding of ['2iI ]Ang 11 to rat adrenal AT, or AT2 receptors.Yd The ability of o-Ala7-Ang-(l-7) to compete for ['251]Ang-(1-7) binding to BAEC with high affinity suggests that it may selectively block responses to Ang-(l-7) in endothelial cells. This is the first characterization of a high-affinity [ '251]Ang-(1-7) binding site in cultured cells. However, we previously showed that ['251]Ang-(1-7) binds to canine dorsal medulla oblongatal7 as well as the rat adrenal and pituitary glands.?8 Ang-(l-7) binding in both the dog and rat was of high affinity (2 to 4 nmol/L) and was specifically displaced by excess unlabeled Ang-( l-7). The ability of Ang-( l-7) to displace [ '251 ]Ang II binding from various tissues and cell types was also investigated. We showed that Ang-( 1-7) was a poor competitor for the AT, receptor on porcine VSMC with an ICZo >l pmol/Ll8 or the AT2 receptor on differentiated NGlO% 15 cells39 and pancreatic acinar cells.40 Ang-(l-7) exhibited little affinity for the Ang IV receptor on BAEC, with an ICro of 800 nmol/L."r In contrast, Ang-(l-7) was a potent competitor for the [ '*'IlAng II binding site on human cardiac fibroblasts, with an ICso of 10 nmol/L,Q and on rat mesangial cells (IC5,=30 nmol/L).41 These results demonstrated that intact tissues contain high-affinity Ang-( 1-7) binding sites and suggest that high-affinity Ang-( l-7) receptors may also be present in the brain, pituitary, adrenal glands, and kidney.
['251]Ang-(1-7) binding to BAEC was not significantly reduced by either the AT, antagonist losartan or the AT2 antagonist PD 123319. Furthermore, the mRNA for the typical AT, or AT2 receptor was not detected in total RNA isolated from BAEC. The absence of an AT, receptor in bovine endothelial cells was not unexpected, since Vaughan et a144 did not find AT, receptor mRNA on Northern blots of total RNA from BAEC, using a cDNA probe against the bovine AT, receptor. These results agree with previous studies by us22 and others2' showing that the endothelial-dependent vasodilation of canine or porcine coronary artery rings by Ang-( l-7) was not inhibited by ATI or AT2 receptor antagonists. In contrast, Stoll et a145 reported that endothelial cells contain both AT, and AT2 receptors that were coupled to the regulation of cell proliferation. However, their endothelial cells were isolated from the coronary vessels of SHR, suggesting variable expression of Ang II receptors in endothelial cells isolated from different species or from hypertensive animals.
[ '251]Ang-( l-7) binding to BAEC was inhibited by Ang-(l-7) in a dose-dependent manner. Comparison of the binding data to models of one-and two-site fits indicated that Ang-(l-7) binds to both a high-and low-affinity site on BAEC (R2=.94; P<.OS for comparison on a one-and two-site fit). The high-affinity site corresponded to the site identified by Scatchard analysis. The low-affinity site may represent binding to an enzyme or to a G-protein-uncoupled form of the receptor. Ang II also competed for [ '*'I]Ang- (1) (2) (3) (4) (5) (6) (7) bmdmg to BAEC in a dose-dependent manner The best-fit curve for binding mhlbltlon by Ang II suggested that Ang II competes for Ang-(l-7) binding at a single site, with an I& of 13 1 nmol/L (R2= .88). This suggests that Ang-(l-7) binds to an endothehal receptor that shows a preference for Ang-(l-7) over Ang II If the data for competition of ['251]Ang-(1-7) bmdmg to BAEC by Ang II are modeled to a two-site fit, both a high-affinity (IC5,= 10 3 nmol/L, 3 1% of the total bmdmg sites) and a low-affinity site (I&=0.5 pmol/L, 69% of the total bmdmg sites) are identified. However, comparison of the onesite and two-site bindmg curves by sum of squares mdlcated that the one-site model best fits the binding data (P= 46) This suggests that Ang II will bmd to the endothelial Ang-( l-7) receptor, albelt at higher concentrations than Ang-( 1-7).
We did not investigate the signal transduction mechanisms coupled to this novel Ang-(l-7) receptor in BAEC However, we previously showed that Ang-(l-7) stimulates the release of prostaglandms from porcine aortlc endotheha1 cells,19 as well as VSMC and astrocytes 153 The depressor effect of Ang-(l-7) m the areflexic rat27 and the vasodllatlon of piglet arterioles by Ang-(l-7)23 were blocked by mhlbltors of prostaglandm synthesis, suggesting that Ang-( l-7) stimulated the release of prostaglandins. In contrast, inhibitors of mtnc oxide synthase blocked the Ang-( 1-7)-mediated vasodllatlon of canine or porcine coronary arteries2is22 and attenuated the depressor effects of Ang-(l-7) m the renovascular dog 25 The vasodllatlon of canine or porcine coronary artenes by Ang-( l-7) was also partially inhibited by the bradykmm B2 antagonist, Hoe 140, suggesting that Ang-( l-7) may interact with the kmm system.21.22 Thus, the Ang-(l-7) receptor on BAEC may be coupled to the release of various autocolds including prostaglandins, mtnc oxide, or kmins Circulating levels of Ang-( l-7) are elevated after treatment of rats, dogs, or humans with ACE mhlbltors.L-6 We recently showed that the plasma concentration of Ang-(l-7) was slgmficantly increased after chronic but not acute therapy with the ACE mhibltor captopnl 3 This agrees with previous studies m which the Ang-(l-7) level m rat plasma was significantly elevated after admmistratlon of ACE inhibitors 4.6 Ang-( l-7) 1s also present m the urme of both rats46 and humans.47 Recent fmdmgs rndlcate that urinary levels of Ang-(l-7) are significantly reduced m patients with essential hypertension and negatively correlate with blood pressure, suggesting that Ang-( 1-7) may function as an endogenous antihypertenslve. 47 We also showed that responses to Ang-(l-7) are potentlated in three different models of hypertension-the SHR, the hypertensive renovascular dog, and the [mRen2]27 hypertensive rat 2.20.25 Systemic infusions of m the SHR caused a slgmficant reduction m the cu-culatmg levels of vasopressm, an increase m urinary prostaglandm excretion, dmresls and natrmresls, and a reduction m mean arterial pressure on day 2 of the infusion 20 Systemic infusion of Ang-(l-7) produced none of these effects m elther normotenslve WKY or Sprague-Dawley rats, suggesting an enhanced responsiveness to Ang-(l-7) m the SHR. The charactenzatlon of a bmdmg site for Ang-(l-7) m endothehal cells m culture will facilitate better understanding of the role of Ang-( l-7) m the regulation of blood pressure In conclusion, BAEC contain a high-affinity Ang-( l-7)
receptor that 1s not a typical ATI or AT2 receptor, The 
